|
09 May 2007 |
Focetria(R), the Novartis pandemic influenza vaccine, receives European Union approval
|
|
04 May 2007 |
Pharmexa starts pivotal phase III trial in the United States
|
|
04 May 2007 |
BioMS Medical Completes Patient Recruitment in MINDSET-01 Phase II Relapsing-Remitting Multiple Sclerosis Trial
|
|
04 May 2007 |
Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
|
|
04 May 2007 |
Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine
|
|
03 May 2007 |
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
|
|
01 May 2007 |
Pharmexa and Bavarian Nordic initiates new NIH funded Phase I trial of two HIV vaccines EP1233 and MVA-BN Polytope in combination
|
|
01 May 2007 |
Advaxis Announces Completion of Patient Accrual in Lovaxin C Phase I/II Trial
|
|
01 May 2007 |
Apollo develops needle-free topical vaccine
|
|
28 Apr 2007 |
Optaflu(R), the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval
|
|
27 Apr 2007 |
Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers' Diarrhea Stimulates Immune Response Even at Low Doses
|
|
26 Apr 2007 |
Novartis expands portfolio of respiratory medicines by acquiring rights to a novel therapeutic vaccine against nicotine addiction
|
|
20 Apr 2007 |
Resistentia Initiates Phase II Clinical Testing of Novel Immunotherapeutic for Allergic Asthma
|
|
19 Apr 2007 |
Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
|
|
18 Apr 2007 |
Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
|
|
18 Apr 2007 |
Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
|
|
17 Apr 2007 |
Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
|
|
17 Apr 2007 |
Generex Biotechnology Vaccine Development Programs Presented at the Annual Meeting of the American Association for Cancer Research
|
|
17 Apr 2007 |
Cervarix(R), GSK cervical cancer candidate vaccine, demonstrates 100 percent protection against precancerous lesions caused by cancer-causing human papillomavirus types 16 & 18 for more than five years
|
|
12 Apr 2007 |
Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases
|
|
06 Apr 2007 |
BioMS Medicals's Pivotal Multiple Sclerosis Trial Receives Positive Interim Safety Analysis
|
|
05 Apr 2007 |
Regulatory approval to start pediatric clinical trials for Japanese Encephalitis (JE) Vaccine in Ind
|
|
05 Apr 2007 |
CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus
|
|
04 Apr 2007 |
Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
|
|
04 Apr 2007 |
LigoCyte Pharmaceuticals Initiates U.S. Clinical Trial Of Norovirus Vaccine
|
